Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer

Welcome introduction and objectives and Treatment for locally advanced/metastatic cutaneous squamous cell carcinoma (CSCC)

Date

22 Sep 2020

Session

Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer

Presenters

Chrysalyne Schmults

Authors

C.D. Schmults

Author affiliations

  • Department Of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Harvard/US
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings